Advertisement

Advertisement

CERO Stock Latest News

CERo Therapeutics Holdings Secures New Consolidated Financing Facility

Company AnnouncementsCERo Therapeutics Holdings Secures New Consolidated Financing Facility

CERo Therapeutics Expands Convertible Debt Financing Arrangement

PremiumCompany Announcements

CERo Therapeutics Expands Convertible Debt Financing Arrangement

3M ago

CERo Therapeutics Amends Convertible Note, Expands Private Financing

PremiumCompany Announcements

CERo Therapeutics Amends Convertible Note, Expands Private Financing

3M ago

CERo Therapeutics Raises Funding via Convertible Note Financing

PremiumCompany Announcements

CERo Therapeutics Raises Funding via Convertible Note Financing

4M ago

CERo Therapeutics Raises Capital via Convertible Note Financing

PremiumCompany Announcements

CERo Therapeutics Raises Capital via Convertible Note Financing

5M ago

CERo Therapeutics Secures Convertible Note Financing Facility

PremiumCompany AnnouncementsCERo Therapeutics Secures Convertible Note Financing Facility

6M ago

CERo Therapeutics Delays 2025 Annual Report Filing

Company Announcements

CERo Therapeutics Delays 2025 Annual Report Filing

6M ago

Cero Therapeutics issues letter to shareholders

The Fly

Cero Therapeutics issues letter to shareholders

7M ago

CERo Therapeutics Enters Convertible Note Financing Agreement

PremiumCompany Announcements

CERo Therapeutics Enters Convertible Note Financing Agreement

7M ago

Cero Therapeutics appoints Eric Francois to board of directors

PremiumThe Fly

Cero Therapeutics appoints Eric Francois to board of directors

8M ago

CERo Therapeutics Announces Convertible Note Financing and New Director

PremiumCompany Announcements

CERo Therapeutics Announces Convertible Note Financing and New Director

8M ago

Cero Therapeutics to present data from Phase 2 trial of CER-1236

PremiumThe Fly

Cero Therapeutics to present data from Phase 2 trial of CER-1236

8M ago

CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial

PremiumCompany AnnouncementsCERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial

8M ago

CERo Therapeutics reports encouraging early CERTAINT-1 trial data

Company Announcements

CERo Therapeutics reports encouraging early CERTAINT-1 trial data

9M ago

Cero Therapeutics provides update on Phase 1 trial of CER-1236

The Fly

Cero Therapeutics provides update on Phase 1 trial of CER-1236

9M ago

CERo Therapeutics shareholders approve key capital structure changes

PremiumCompany Announcements

CERo Therapeutics shareholders approve key capital structure changes

10M ago

Cero Therapeutics provides update on Phase 1 trial of CER-1236

PremiumThe Fly

Cero Therapeutics provides update on Phase 1 trial of CER-1236

10M ago

CERo Therapeutics Enters New $14.6M Stock Agreement

PremiumCompany Announcements

CERo Therapeutics Enters New $14.6M Stock Agreement

10M ago

Cero Therapeutics announces trading on OTCQB Market

PremiumThe Fly

Cero Therapeutics announces trading on OTCQB Market

10M ago

Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital

PremiumThe FlyCero Therapeutics downgraded to Hold from Buy at D. Boral Capital

11M ago

CERo Therapeutics Delays Quarterly Report Filing

Company Announcements

CERo Therapeutics Delays Quarterly Report Filing

11M ago

Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236

The Fly

Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >